These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36372869)

  • 1. Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events.
    Sakuma M; Iimuro S; Shinozaki T; Kimura T; Nakagawa Y; Ozaki Y; Iwata H; Miyauchi K; Daida H; Suwa S; Sakuma I; Nishihata Y; Saito Y; Ogawa H; Matsuzaki M; Ohashi Y; Taguchi I; Toyoda S; Inoue T; Nagai R
    BMC Med; 2022 Nov; 20(1):441. PubMed ID: 36372869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Versus Low-Dose Pitavastatin in Japanese Patients With Stable Coronary Artery Disease (REAL-CAD): A Randomized Superiority Trial.
    Taguchi I; Iimuro S; Iwata H; Takashima H; Abe M; Amiya E; Ogawa T; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Miyauchi K; Yamazaki T; Ito H; Otsuji Y; Kimura K; Takahashi J; Hirayama A; Yokoi H; Kitagawa K; Urabe T; Okada Y; Terayama Y; Toyoda K; Nagao T; Matsumoto M; Ohashi Y; Kaneko T; Fujita R; Ohtsu H; Ogawa H; Daida H; Shimokawa H; Saito Y; Kimura T; Inoue T; Matsuzaki M; Nagai R
    Circulation; 2018 May; 137(19):1997-2009. PubMed ID: 29735587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Density Lipoprotein Cholesterol and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Statins: An Observation from the REAL-CAD Study.
    Omote K; Yokota I; Nagai T; Sakuma I; Nakagawa Y; Kamiya K; Iwata H; Miyauchi K; Ozaki Y; Hibi K; Hiro T; Fukumoto Y; Mori H; Hokimoto S; Ohashi Y; Ohtsu H; Ogawa H; Daida H; Iimuro S; Shimokawa H; Saito Y; Kimura T; Matsuzaki M; Nagai R; Anzai T
    J Atheroscler Thromb; 2022 Jan; 29(1):50-68. PubMed ID: 33431716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treat-to-target or high-intensity statin treatment in older adults with coronary artery disease: a post hoc analysis of the LODESTAR trial.
    Lee SJ; Lee JB; Yang TH; Kang WC; Lee JY; Lee YJ; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Hong BK; Choi D; Yoon J; Jang Y; Hong MK;
    Age Ageing; 2024 Jul; 53(7):. PubMed ID: 38965031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and Design of Randomized Evaluation of Aggressive or Moderate Lipid Lowering Therapy with Pitavastatin in Coronary Artery Disease (REAL-CAD) Trial.
    Miyauchi K; Kimura T; Shimokawa H; Daida H; Iimuro S; Iwata H; Ozaki Y; Sakuma I; Nakagawa Y; Hibi K; Hiro T; Fukumoto Y; Hokimoto S; Ohashi Y; Ohtsu H; Saito Y; Matsuzaki M; Nagai R;
    Int Heart J; 2018 Mar; 59(2):315-320. PubMed ID: 29503404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE.
    Gaba P; O'Donoghue ML; Park JG; Wiviott SD; Atar D; Kuder JF; Im K; Murphy SA; De Ferrari GM; Gaciong ZA; Toth K; Gouni-Berthold I; Lopez-Miranda J; Schiele F; Mach F; Flores-Arredondo JH; López JAG; Elliott-Davey M; Wang B; Monsalvo ML; Abbasi S; Giugliano RP; Sabatine MS
    Circulation; 2023 Apr; 147(16):1192-1203. PubMed ID: 36779348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals.
    Nakamura T; Obata JE; Hirano M; Kitta Y; Fujioka D; Saito Y; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Kugiyama K
    Atherosclerosis; 2011 Sep; 218(1):163-7. PubMed ID: 21605862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Density Lipoprotein Cholesterol Levels on Statins and Cardiovascular Event Risk in Stable Coronary Artery Disease　- An Observation From the REAL-CAD Study.
    Toyota T; Morimoto T; Iimuro S; Fujita R; Iwata H; Miyauchi K; Inoue T; Nakagawa Y; Nishihata Y; Daida H; Ozaki Y; Suwa S; Sakuma I; Furukawa Y; Shiomi H; Watanabe H; Yamaji K; Saito N; Natsuaki M; Ohashi Y; Matsuzaki M; Nagai R; Kimura T
    Circ J; 2023 Jan; 87(2):360-367. PubMed ID: 36104250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yield of Dual Therapy With Statin and Ezetimibe in the Treat Stroke to Target Trial.
    Amarenco P; Kim JS; Labreuche J; Charles H; Giroud M; Lee BC; Lavallée PC; Mahagne MH; Meseguer E; Nighoghossian N; Steg PG; Vicaut É; Bruckert E;
    Stroke; 2022 Nov; 53(11):3260-3267. PubMed ID: 36154103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Non-Lipid Residual Risk Factors and Cardiovascular Events in Patients with Stable Coronary Artery Disease Treated with Pitavastatin: An Observation from the REAL-CAD Study.
    Kamiya K; Takei M; Nagai T; Miyoshi T; Ito H; Fukumoto Y; Obara H; Kakuma T; Sakuma I; Daida H; Iimuro S; Shimokawa H; Kimura T; Nagai R; Anzai T
    J Atheroscler Thromb; 2024 Jan; 31(1):61-80. PubMed ID: 37574272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70-100 mg/dL in Taiwan.
    Lin FJ; Shyu KG; Hsieh IC; Huey-Herng Sheu W; Tu ST; Yeh SJ; Chen CI; Lu KC; Wu CC; Shau WY; Inocencio TJ; Wen YC; Yeh HI
    J Formos Med Assoc; 2020 May; 119(5):907-916. PubMed ID: 32081563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.
    Vallejo-Vaz AJ; Fayyad R; Boekholdt SM; Hovingh GK; Kastelein JJ; Melamed S; Barter P; Waters DD; Ray KK
    Circulation; 2018 Aug; 138(8):770-781. PubMed ID: 29618599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Low Baseline Low-Density Lipoprotein Cholesterol on Long-Term Postdischarge Cardiovascular Outcomes in Patients With Acute Myocardial Infarction.
    Cho KH; Kim MC; Choo EH; Choi IJ; Lee SN; Park MW; Park CS; Kim HY; Kim CJ; Sim DS; Kim JH; Hong YJ; Jeong MH; Chang K; Ahn Y
    J Am Heart Assoc; 2022 Sep; 11(17):e025958. PubMed ID: 36000434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More Than 50 Percent Reduction in LDL Cholesterol in Patients With Target LDL <70 mg/dL After a Stroke.
    Amarenco P; Lavallée PC; Kim JS; Labreuche J; Charles H; Giroud M; Lee BC; Mahagne MH; Meseguer E; Nighoghossian N; Steg PG; Vicaut É; Bruckert E;
    Stroke; 2023 Aug; 54(8):1993-2001. PubMed ID: 37376989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desirable Low-Density Lipoprotein Cholesterol Levels for Preventing Stroke Recurrence: A Post Hoc Analysis of the J-STARS Study (Japan Statin Treatment Against Recurrent Stroke).
    Hosomi N; Kitagawa K; Nagai Y; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
    Stroke; 2018 Apr; 49(4):865-871. PubMed ID: 29511130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma ANGPTL8 Levels and Risk for Secondary Cardiovascular Events in Japanese Patients With Stable Coronary Artery Disease Receiving Statin Therapy.
    Morinaga J; Kashiwabara K; Torigoe D; Okadome Y; Aizawa K; Uemura K; Kurashima A; Matsunaga E; Fukami H; Horiguchi H; Sato M; Sugizaki T; Miyata K; Kadomatsu T; Mukoyama M; Miyauchi K; Hokimoto S; Fukumoto Y; Hiro T; Hibi K; Nakagawa Y; Sakuma I; Ozaki Y; Iwata H; Iimuro S; Daida H; Shimokawa H; Kimura T; Matsuzaki M; Saito Y; Matsuyama Y; Nagai R; Oike Y
    Arterioscler Thromb Vasc Biol; 2023 Aug; 43(8):1549-1559. PubMed ID: 37259862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.